Semaglutide Rocketing Past Statins as Millions Eligible
A new study suggests that 40% of American adults have conditions that could benefit from semaglutide treatment.
Related Articles
The Efficacy and Safety of Mirvetuximab Soravtansine in FRα-Positive, Third-Line and Later, Recurrent Platinum-Sensitive Ovarian Cancer: The Single-Arm Phase 2 PICCOLO Trial
Mirvetuximab soravtansine-gynx (MIRV) is a first-in-class, folate receptor alpha (FRα)-targeting antibody-drug conjugate with US Food and Drug Administration approval for FRα-positive platinum-resistant ovarian cancer. PICCOLO…
Healthcare Workers vs Hunger
Healthcare workers vs Hunger is an annual friendly competition between teams of healthcare workers to help relieve food insecurity.
Recent Advances towards the Understanding of Secondary Acute Myeloid Leukemia Progression
Secondary acute myeloid leukemia (sAML) is a heterogeneous malignant hematopoietic disease that arises either from an antecedent hematologic disorder (AHD) including myelodysplastic syndromes (MDS), myeloproliferative…
Elon Musk: the ‘wild card’ in Trump’s dealings with China
Do the billionaire’s longstanding ties to Beijing represent a diplomatic opportunity or a clash of political and business interests?
An integrated single-cell atlas of blood immune cells in aging
npj Aging – An integrated single-cell atlas of blood immune cells in aging
Age-related decline in CD8+ tissue resident memory T cells compromises antitumor immunity
Nature Aging – Exploring how aging compromises antitumor immunity, the authors reveal an age-related impairment of cytotoxic CD8+ TRM cells in mouse tumor models and…
An immigration fix to address the health care workforce crisis
Former HHS Secretary Tom Price writes that the new Trump administration should update immigration laws to help the U.S. health care workforce crisis.
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Hematologic Cancers | Research To Practice
ASH CME Hybrid Events | December 6, 2024, San Diego, California Schedule of Events All events are free of
Long COVID appears to be driven by ‘long infection’. Here’s what the science says
Much, if not all, long COVID appears to be driven by the virus persisting in the body. Formal proof remains elusive but here’s what the…
The evolving landscape of von Willebrand disease diagnosis
In their review article, O’Donnell et al. 2024 outline previous and existing challenges in the diagnosis of von Willebrand disease (VWD) and describe a potential path…
